Agree Acca, however surely (don't call me shirly) you would agree this stock is very frustrating, with great contracts being signed ....and no/hardly any revenue to speak of......GLTA
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ASX Market Open: Powell hope to power Santa rally through French gov't collapse, South Korean crisis | Dec 5, 2024
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025